A Comprehensive Overview of US-FDA-Approved Anticancer Drugs and Biologics in 2023: An Observational Study

A Comprehensive Overview of US-FDA-Approved Anticancer Drugs and Biologics in 2023: An Observational Study

Background: The United States Food and Drug Administration (US FDA) is responsible for ensuring public health by conducting a comprehensive assessment and approval of pharmaceuticals, medical devices, and food products. The federal agency conducts a thorough evaluation of drug safety and efficacy be...

Full description

Saved in:
Bibliographic Details
Main Authors: Ajay Kumar Shukla, Saurav Misra
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Journal of Pharmacy and Bioallied Sciences
Subjects:
anticancer drugs
biologicals
drug development
new drug approvals
us fda
Online Access:https://journals.lww.com/10.4103/jpbs.jpbs_730_25
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items